UPDATE : Monday, February 17, 2020
Samsung BioLogics caught red-handed destroying evidence by Jeong Sae-im 2019-12-28 12:17
2nd rare cancer reported in Korea regarding Allergan’s breast implant by Jeong Sae-im 2019-12-27 10:30
Local biopharmaceutical companies suffer from unsatisfactory P3 global trial results by Jeong Sae-im 2019-12-27 07:06
Humedix wins patent on new anti-aging material by Jeong Sae-im 2019-12-26 14:31
Regulator warns of serious breathing difficulties in gabapentinoid use by Jeong Sae-im 2019-12-24 11:41
Vaxcell-Bio Therapeutics passes tech review for Kosdaq debut by Jeong Sae-im 2019-12-23 15:42
Pfizer wins Champix patent suit against 20 local generics makers by Jeong Sae-im 2019-12-20 16:28
Kolon appeals Invossa’s safety in pleading at court by Jeong Sae-im 2019-12-20 14:57
4 firms to offer up to 56 direct-to-consumer genetic testing services by Jeong Sae-im 2019-12-19 16:40
QuantaMatrix passes technology review for Kosdaq listing by Jeong Sae-im 2019-12-19 14:21
4 new botulinum toxins to undergo trials in crowded market by Jeong Sae-im 2019-12-18 15:29
Venture capital investment in biomedical sector to hit record this year by Jeong Sae-im 2019-12-17 14:20
Helixmith to clarify why gene therapy study had data error by Jeong Sae-im 2019-12-13 15:13
Yuhan to start phase-3 trial on lung cancer drug Lazertinib by Jeong Sae-im 2019-12-12 15:04
Aprogen, 1st Korean biotech firm to win unicorn status by Jeong Sae-im 2019-12-11 13:10
Samsung execs get jail term for destroying evidence by Jeong Sae-im 2019-12-10 11:43
SK Biopharm set to ensure superiority in antiepileptic drug by Jeong Sae-im 2019-12-04 16:18
Samyang Biopharm’s US subsidiary to work on new immunotherapy by Jeong Sae-im 2019-12-03 15:37
Alteogen inks licensing-out deal for SC injection formulation technology by Jeong Sae-im 2019-12-02 15:25
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan by Jeong Sae-im 2019-11-29 15:23
Back to Top